Questcor Pharmaceuticals, Inc. Buyback
OLI recorded this information on 12/11/2013
Questcor Pharmaceuticals, Inc.
Shares Announced Repurchased:
The Company also announced today that it made open market purchases during the fourth quarter of 2013 of approximately 500,000 shares of Questcor common stock through December 10, 2013. The shares were purchased at an average price of $57.21 per share.
Questcor Pharmaceuticals is a biopharmaceutical company focused on the treatment of patients with autoimmune and inflammatory disorders. Co. also supplies contract manufacturing services to the global pharmaceutical and biotechnology industry through its wholly-owned subsidiary, BioVectra Inc. Co. manages its operations through two operating segments: Questcor Pharmaceuticals, Inc., whose primary product is H.P. Acthar® Gel (repository corticotropin injection), or Acthar, an injectable drug for the treatment of 19 indications; and BioVectra, Inc.; which is a supplier of contract manufacturing services to the global pharmaceutical and biotechnology industry.
Open the QCOR Page at The Online Investor »
Free QCOR Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Hold (2.00 out of 4)
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite